NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-083-2002-2-PCT-01 Use Of Discoidan Domain Receptor 1 (DDR1) And Agents That Affect The DDR1/Collagen Pathway PCT PCT COMB PCT/US02/39793 Expired
NCI E-321-2002-0-US-02 New Genes and Proteins Expressed in Breast Cancer. US 60/432,531 Abandoned
NIDDK E-166-2001-0-PCT-02 HGC-1 A Gene Encoding a Member of The Olfactomedin-Related Protein Family PCT PCT PCT/US02/39148 Expired
NCI E-029-2002-0-PCT-02 PEPTIDE T STIMULATES CTL RESPONSES PCT PCT PCT/US02/39109 Abandoned
NHLBI E-185-2002-0-US-01 Particles for Imaging Cells US ORD 10/313,304 Abandoned
NCI E-317-2001-0-EP-04 Compounds to Treat HIV Infection and AIDS EP National Stage 02795784.4 Abandoned
NCI E-317-2001-0-PCT-02 Compounds to Treat HIV Infection and AIDS PCT PCT PCT/US02/39254 Expired
NCI E-216-2000-2-US-02 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES US National Stage 10/297,337 Abandoned
NCI E-091-2002-0-CA-03 Zap70 Protein Expression as a Marker for Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL) CA ORD 2413475 Expired
NCI E-091-2002-0-US-02 Zap-70 Protein Expression as a Marker for Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL) US ORD 10/309,548 7329502 Expired PDF
NCI E-163-1997-0-US-08 CYCLIN DEPENDENT KINASE (CDK4) INHIBITORS AND THEIR USE FOR TREATING CANCER US DIV 10/308,343 Abandoned
NCI E-010-1999-1-US-03 TREATMENT OF KAPOSI'S SARCOMA WITH IL-12 US DIV 10/307,295 Abandoned
NCI E-051-2003-0-US-01 IN-VITRO AND IN-VIVO CYTOTOXIC ACTIVITIES OF RECOMBINANT IMMUNOTOXIN 8H9 (Fv)-PE38 AGAINST BREAST CANCER, OSTEOCARCINOMA AND NEUROBLASTOMA US 60/430,305 Abandoned
NINDS E-143-2002-0-CA-05 Method of Treating Autoimmune Diseases with Interferon-Beta and IL-2R Antagonist CA National Stage 2490804 Abandoned
NINDS E-143-2002-0-AU-06 Method of Treating Autoimmune Diseases with Interferon-Beta and IL-2R Antagonist AU National Stage 2002368055 Abandoned
NICHD E-147-1996-5-US-02 Use of Activity-Dependent Neutrophic Factor-Derived Polypeptides for Enhancing Learning And Memory US National Stage 10/296,849 7427598 Abandoned PDF
NICHD E-147-1996-5-NZ-05 USE OF ADNF FOR ENHANCING LEARNING AND MEMORY NZ National Stage 522821 Expired
NINDS E-143-2002-0-PCT-02 Method of Treating Autoimmune Diseases with Interferon-Beta and IL-2R Antagonist PCT PCT PCT/US02/38290 Expired
NIDDK E-026-2002-0-PCT-02 P2X7 Receptor Antagonists PCT PCT PCT/US02/38126 Expired
NICHD E-054-2000-0-US-03 USE AND TARGETING OF CD98 LIGHT-CHAIN PROTEINS IN THERAPIES FOR THYROID HORMONE DISORDERS US National Stage 10/307,063 Abandoned
NINDS E-143-2002-0-JP-09 Method of Treating Autoimmune Diseases with Interferon-Beta and IL-2R Antagonist JP DIV 2011-082497 Abandoned
NIEHS E-336-2003-0-US-01 Glyceraldehyde 3-phosphate Dehydrogenase-S (GAPDS), A Glycolytic Enzyme Expressed Only In Male Germ Cells Is A Target For Male Contraception US 60/429,638 Abandoned
NINDS E-143-2002-0-EP-07 Method of Treating Autoimmune Diseases with Interferon-Beta and IL-2R Antagonist EP National Stage 02807575.2 Abandoned
NCI E-124-2001-1-CA-03 Peptide Agonists of Prostate-Specific Antigen (PSA) and Uses Therefor CA National Stage 2468258 Expired
NCI E-124-2001-1-EP-04 Peptide Agonists of Prostate-Specific Antigen, and Uses Therefor EP National Stage 02789873.3 Expired
NCI E-124-2001-1-JP-06 Peptide Agonists of Prostrate-Specific Antigen, and Uses Therefor JP National Stage 2003-548767 Expired
NCI E-124-2001-1-AU-05 PEPTIDE AGONISTS OF PROSTATE-SPECIFIC ANTIGEN AND USES THEREFOR AU National Stage 2002352913 Expired
NCI E-124-2001-1-PCT-01 Peptide Agonists of Prostate-Specific Antigen (PSA), and Uses Therefor PCT PCT COMB PCT/US2002/037805 Expired
NHGRI E-002-1998-0-US-04 TUMOR TISSUE MICROARRAYS FOR RAPID MOLECULAR PROFILING US CON 10/305,800 Abandoned
NCI E-339-2002-0-US-01 Device for External Movement Manipulation of Nucleic Acids and/or Proteins US 60/428,754 Abandoned
NCI E-104-1996-1-US-02 BASAL CELL CARCINOMA TUMOR SUPPRESSOR PROTEIN US CON 10/302,279 7317086 Abandoned PDF
NINDS E-237-1999-0-US-07 Methods For Preventing Strokes By Inducing Tolerance To e-selectin US National Stage 10/296,423 7261896 Abandoned PDF
NCI E-152-2007-0-US-09 Non-M Non-O HiV Strains, Fragments And Uses US DIV 10/301,661 7030234 Expired PDF
NIAID E-280-2001-0-EP-06 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) From cDNA EP National Stage 02799195.9 Abandoned
NIAID E-280-2001-0-IE-13 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) From cDNA IE EP 02799195.9 Abandoned
NIAID E-280-2001-0-FR-11 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) From cDNA FR EP 02799195.9 Abandoned
NIAID E-280-2001-0-DE-10 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) From cDNA DE EP 02799195.9 Abandoned
NIAID E-280-2001-0-GB-12 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) From cDNA GB EP 02799195.9 Abandoned
NIAID E-280-2001-0-CH-09 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) From cDNA CH EP 02799195.9 Abandoned
NIAID E-280-2001-0-US-02 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) From cDNA and Use of Recombinant HPIV1 as Vaccines And Vectors to ... US DIV 10/302,547 7704509 Expired PDF
NIAID E-280-2001-0-AU-04 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) from cDNA AU National Stage 2002364121 Abandoned
NIAID E-280-2001-0-PCT-03 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) From cDNA and Use of Recombinant HPIV In Immunogenic Compositions and as Vectors to Elicit Immune Response Against PIV and Other Human Pathogens PCT PCT PCT/US02/37688 Expired
NIAID E-280-2001-0-EP-07 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) From cDNA EP DIV 09162824.8 Abandoned
NIAID E-280-2001-0-CA-05 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) From cDNA CA National Stage 2467958 Abandoned
NHLBI E-151-1991-1-US-02 ADENOVIRUS MEDIATED TRANSFER OF GENES TO THE GASTROINTESTINAL TRACT US CON 10/300,209 Abandoned
NIDDK E-248-1999-0-US-03 High Throughput Infrared Spectroscopy US ORD 10/299,577 7391025 Abandoned PDF
NCI E-031-2003-0-US-01 Immunogenic Epitopes For Fibroblast Growth Factor 5 (FGF-5) Presented By HLA-A3 And HLA-A2 US 60/427,920 Abandoned
NIMH E-044-1997-1-US-06 IMMUNOTOXIN FUSION PROTEINS AND MEANS FOR EXPRESSION THEREOF US National Stage 10/296,085 7696338 Expired PDF
NCI E-070-2000-0-US-06 INHIBITION OF SMAD3 TO PREVENT FIBROSIS AND TO IMPROVE WOUND HEALING US ORD 10/299,886 Abandoned
NCI E-158-2000-0-PCT-02 Novel Chimeric Rev, TAT and NEF Antigens PCT PCT PCT/US2002/036805 Expired